Prognostic significance of a positive microscopic margin in high-risk extremity soft tissue sarcoma: Implications for management

被引:77
作者
Heslin, MJ
Woodruff, J
Brennan, MF
机构
[1] MEM SLOAN KETTERING CANC CTR, DEPT SURG, NEW YORK, NY 10021 USA
[2] MEM SLOAN KETTERING CANC CTR, DEPT PATHOL, NEW YORK, NY 10021 USA
关键词
D O I
10.1200/JCO.1996.14.2.473
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: A positive microscopic margin (PMM) is a significant prognostic variable and leads to local recurrence (LR) in high-grade soft tissue sarcoma (STS) patients. Its effect on the rate of distant metastasis (DM) and tumor mortality (TM) remains controversial. Patients and Methods: One hundred sixty-eight primary, high-risk (high-grade, deep, greater than or equal to 5 cm) extremity STS patients were identified from our data base, of which 42 had a PMM, Limb-sparing surgery (LSS) was the primary surgical therapy in 144 patients; 24 received amputation (AMP). Statistical analysis was by log-rank test and Cox model, Significance was defined as a P value less than .05. Results: A PMM was a significant negative prognostic factor for both DM and TM (P = .002 and .002, respectively), However, those patients who received LSS with 28% PMMs showed no significant difference in the rate of DM or TM compared with patients who received AMP with only 8% PMMs (log-rank, P = .057 and .28, respectively). A PMM was significantly associated with greater than or equal to 1,000 ml blood loss and more than 3 hours of operating time (P < .006 and .001, respectively). Conclusion: The strong statistical significance that relates a PMM to DM and TM in high-risk STS of the extremity is likely related to biologically aggressive tumors and LSS, Residual microscopic disease is not a guarantee of LR. The main problem in this group of patients is not LR, but DM and subsequent death. Therefore, to increase a disability with further surgery or amputate a patient's limb without clear evidence of LR in this group at high risk for distant recurrence is not recommended. (C) 1996 by American Society of Clinical Oncology.
引用
收藏
页码:473 / 478
页数:6
相关论文
共 20 条
[1]  
BRENNAN MF, 1987, ARCH SURG-CHICAGO, V122, P1289
[2]   PROBLEM OF LOCAL RECURRENCE AFTER TREATMENT OF SOFT TISSUE SARCOMA [J].
CANTIN, J ;
MCNEER, GP ;
CHU, FC ;
BOOHER, RJ .
ANNALS OF SURGERY, 1968, 168 (01) :47-&
[3]   PROGNOSTIC FACTORS FOR LOCAL RECURRENCE AND SURVIVAL IN PATIENTS WITH LOCALIZED EXTREMITY SOFT-TISSUE SARCOMA [J].
COLLIN, CF ;
FRIEDRICH, C ;
GODBOLD, J ;
HAJDU, S ;
BRENNAN, MF .
SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (01) :30-37
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]   REFINEMENT OF CLINICOPATHOLOGICAL STAGING FOR LOCALIZED SOFT-TISSUE SARCOMA OF THE EXTREMITY - A STUDY OF 423 ADULTS [J].
GAYNOR, JJ ;
TAN, CC ;
CASPER, ES ;
COLLIN, CF ;
FRIEDRICH, C ;
SHIU, M ;
HAJDU, SI ;
BRENNAN, MF .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (08) :1317-1329
[6]  
GUSTAFSON P, 1991, CANCER, V67, P2083, DOI 10.1002/1097-0142(19910415)67:8<2083::AID-CNCR2820670813>3.0.CO
[7]  
2-5
[8]   SELECTION BIAS IN TREATMENT OF SOFT-TISSUE SARCOMA [J].
GUSTAFSON, P ;
RYDHOLM, A .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1992, 74 (04) :501-503
[9]  
HERBERT SH, 1993, CANCER, V72, P1230, DOI 10.1002/1097-0142(19930815)72:4<1230::AID-CNCR2820720416>3.0.CO
[10]  
2-J